Abstract:Study Type Diagnostic (exploratory cohort) Level of Evidence 2b What's known on the subject? and What does the study add? The present study was to perform contrast-tuned imaging (CnTI) technology to detect prostate cancer and compare the use of CnTI technology for the detection of prostate cancer with conventional ultrasonography. The preliminary data from our study suggested that targeted biopsy of the prostate with CnTI technology could improve the cancer detection and detect higher grade prostate cancers. OBJECTIVES To perform contrast-enhanced ultrasonography (CEUS) using contrast-tuned imaging (CnTI) technology to detect prostate cancer. To evaluate the detection of prostate cancer with CnTI compared with conventional grey-scale and power Doppler ultrasonography. PAIENTS AND METHODS In all, 150 patients referred for prostate biopsy were evaluated using transrectal grey-scale, power Doppler and CnTI ultrasonography. Biopsy was performed at 10 sites in each patient. If an abnormality was found at any of these three ultrasonography examinations, a biopsy specimen was targeted towards from the corresponding site. The performances of the three ultrasonography techniques for prostate cancer detection were compared. RESULTS Prostate cancer was detected at 383 sites from 73 patients. The combination of these three examinations detected more patients with prostate cancer than grey-scale (P= 0.002), power Doppler (P= 0.001) or baseline imaging (the combination of grey-scale and power Doppler; P= 0.031) alone. By biopsy site, CnTI had higher sensitivity and accuracy (73.1% and 83.7%) than grey-scale (50.9%; P < 0.001 and 78.8%; P < 0.001) or power Doppler (48.3%; P < 0.001 and 77.7%; P < 0.001), while the specificity was similar for grey-scale (88.4%), power Doppler (87.8%) and CnTI (87.3%; P > 0.05 in each case). CnTI had higher sensitivity (73.1% vs 62.9%; P < 0.001), specificity (87.3% vs 82.1%; P < 0.001) and accuracy (83.7% vs 77.2%; P < 0.001) than baseline imaging. The mean Gleason score of CnTI-positive cases was significantly higher than CnTI-negative cases (7.1 vs 6.3; P= 0.002). CONCLUSIONS CEUS using CnTI technology enables a visualization of the microvasculature associated with prostate cancer. CnTI technology could be used to guide biopsy and improve the detection rate of prostate cancer. CnTI technology was able to detect higher grade prostate cancers.

Enhancement Characteristics of Benign and Malignant Focal Peripheral Nodules in the Peripheral Zone of the Prostate Gland Studied Using Contrast-Enhanced Transrectal Ultrasound.

Contrast-enhanced Transrectal Ultrasound for Assessing Vascularization of Hypoechoic Benign Hyperplastic Nodules in the Transition and Peripheral Zones of the Prostate: Comparison with Pathological Examination

Value of contrast-enhanced transrectal ultrasound in diagnosis of benign and malignant focal nodules in the peripheral zone of the prostate gland

Value of Contrast-Enhanced Ultrasound and Enhancement Patterns in the Diagnosis of Adrenal Tumors

Significance of contrast-enhanced transrectal ultrasonography for the detection of prostate cancer

Transrectal contrast enhanced ultrasound in distinguishing benign from malignant nodes of prostate

Identification Value of Contrast-Enhanced Sonography on Peripheral Pulmonary Cancer

Utility of Quantitative Contrast-Enhanced Ultrasound for the Prediction of Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma

The Value of Contrast Enhanced Ultrasound in Diagnosis of Benign and Malignant Prostatic Neoplasms

Added Value of Contrast-Enhanced Ultrasound to Conventional Ultrasound for Characterization of Indeterminate Soft-Tissue Tumors.

The utility and limitations of contrast-enhanced transrectal ultrasound scanning for the detection of prostate cancer in different area of prostate.

The value of contrast-enhanced transrectal ultrasound in predicting the nature of prostate diseases and the gleason score of prostate cancer by a subjective blood flow grading scale

Quantitative analysis with contrast-enhanced ultrasonography in evaluating perfusion characteristics of outer gland of prostate cancer in patients with negative finding by conventional ultrasound

Value of Contrast-enhanced Ultrasound in Diagnosis of Prostate Cancer

Preliminary Study of Contrast-Enhanced Ultrasound in the Diagnosis of Prostatic Nodules

Contrast-enhanced Transrectal Ultrasonography for Detection and Localization of Prostate Index Tumor: Correlation with Radical Prostatectomy Findings.

[A Preliminary Study of Contrast-Enhanced Ultrasound in Benign Prostatic Hyperplasia].

Evaluation of Characteristics of Thyroid Nodules on Contrast-Enhanced Ultrasonography: a Retrospective Analysis of 252 Cases

Investigation of ultrasonographic feature and resistive index in benign disease of prostatic peripheral zone

Editorial Comment to Contrast-Enhanced Transrectal Ultrasonography: Measurement of Prostate Cancer Tumor Size and Correlation with Radical Prostatectomy Specimens

Contrast-enhanced ultrasonography with contrast-tuned imaging technology for the detection of prostate cancer: Comparison with conventional ultrasonography